APA (7th ed.) Citation

B, K., SA, I., SW, H., HS, H., MA, K., DY, O., . . . Lee, S. (2008). Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker. BMC Cancer, 8, 148. https://doi.org/10.1186/1471-2407-8-148

Chicago Style (17th ed.) Citation

B, Keam, et al. "Modified FOLFOX-6 Chemotherapy in Advanced Gastric Cancer: Results of Phase II Study and Comprehensive Analysis of Polymorphisms as a Predictive and Prognostic Marker." BMC Cancer 8 (2008): 148. https://doi.org/10.1186/1471-2407-8-148.

MLA (9th ed.) Citation

B, Keam, et al. "Modified FOLFOX-6 Chemotherapy in Advanced Gastric Cancer: Results of Phase II Study and Comprehensive Analysis of Polymorphisms as a Predictive and Prognostic Marker." BMC Cancer, vol. 8, 2008, p. 148, https://doi.org/10.1186/1471-2407-8-148.